Healthcare provider profile · identity verified

Daryoush Khoshrou

Family Practice · SANTA ANA, CA · NPI 1235210766

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	592	175
Amlodipine Besylate	Amlodipine Besylate	462	128
Losartan Potassium	Losartan Potassium	426	122
Levothyroxine Sodium	Levothyroxine Sodium	302	85
Lisinopril	Lisinopril	266	72
Metformin Hcl	Metformin Hcl	262	76
Tamsulosin Hcl	Tamsulosin Hcl	261	84
Alendronate Sodium	Alendronate Sodium	241	84
Rosuvastatin Calcium	Rosuvastatin Calcium	231	71
Hydrochlorothiazide	Hydrochlorothiazide	209	61
Simvastatin	Simvastatin	188	52
Gabapentin	Gabapentin	175	62
Pravastatin Sodium	Pravastatin Sodium	153	48
Pantoprazole Sodium	Pantoprazole Sodium	149	57
Trazodone Hcl	Trazodone Hcl	146	48
Omeprazole	Omeprazole	143	47
Azelastine Hcl	Azelastine Hcl	139	77
Metoprolol Tartrate	Metoprolol Tartrate	125	40
Azithromycin	Azithromycin	117	82
Albuterol Sulfate Hfa	Albuterol Sulfate	113	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	112	21
Metoprolol Succinate	Metoprolol Succinate	110	33
Metformin Hcl Er	Metformin Hcl	104	34
Alprazolam	Alprazolam	102	21
Donepezil Hcl	Donepezil Hcl	101	31
Escitalopram Oxalate	Escitalopram Oxalate	91	30
Famotidine	Famotidine	84	25
Triamcinolone Acetonide	Triamcinolone Acetonide	84	56
Fluticasone Propionate	Fluticasone Propionate	81	41
Finasteride	Finasteride	78	22
Meloxicam	Meloxicam	75	23
Methylprednisolone	Methylprednisolone	70	49
Ozempic	Semaglutide	70	11
Januvia	Sitagliptin Phosphate	66	24
Montelukast Sodium	Montelukast Sodium	66	20
Diclofenac Sodium	Diclofenac Sodium	63	28
Eliquis	Apixaban	61	17
Furosemide	Furosemide	61	20
Allopurinol	Allopurinol	60	15
Duloxetine Hcl	Duloxetine Hcl	59	14
Jardiance	Empagliflozin	58	19
Carvedilol	Carvedilol	55	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	54	40
Sertraline Hcl	Sertraline Hcl	52	14
Ezetimibe	Ezetimibe	50	14
Tramadol Hcl	Tramadol Hcl	49	18
Ibuprofen	Ibuprofen	48	21
Propranolol Hcl	Propranolol Hcl	48	16
Fluoxetine Hcl	Fluoxetine Hcl	47	13
Clopidogrel	Clopidogrel Bisulfate	46	16
Linzess	Linaclotide	45	suppressed
Synthroid	Levothyroxine Sodium	42	12
Atenolol	Atenolol	41	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	14
Valsartan	Valsartan	41	12
Benazepril Hcl	Benazepril Hcl	40	12
Mirtazapine	Mirtazapine	37	12
Cefuroxime	Cefuroxime Axetil	35	30
Lactulose	Lactulose	35	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Glipizide	Glipizide	34	suppressed
Temazepam	Temazepam	34	suppressed
Trulicity	Dulaglutide	34	suppressed
Hydrocortisone	Hydrocortisone	33	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	14
Lorazepam	Lorazepam	32	11
Pioglitazone Hcl	Pioglitazone Hcl	32	11
Celecoxib	Celecoxib	31	11
Cephalexin	Cephalexin	31	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	11
Lagevrio (Eua)	Molnupiravir	30	28
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	22
Hydralazine Hcl	Hydralazine Hcl	28	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Potassium Chloride	Potassium Chloride	28	11
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Lidocaine	Lidocaine	26	suppressed
Meclizine Hcl	Meclizine Hcl	25	15
Tizanidine Hcl	Tizanidine Hcl	25	12
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Sildenafil Citrate	Sildenafil Citrate	24	suppressed
Baclofen	Baclofen	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Atrovent Hfa	Ipratropium Bromide	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Ketoconazole	Ketoconazole	21	13
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Nystatin	Nystatin	20	11
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fluocinonide	Fluocinonide	16	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Procto-Med Hc	Hydrocortisone	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	15	12
Pregabalin	Pregabalin	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Amoxicillin	Amoxicillin	14	12
Buspirone Hcl	Buspirone Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Prednisone	Prednisone	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Tobramycin	Tobramycin	13	13
Veltassa	Patiromer Calcium Sorbitex	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Naproxen	Naproxen	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error